{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:53:27Z","timestamp":1793847207466,"version":"4.6.1"},"reference-count":44,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Background: Hepatocellular carcinoma (HCC) is characterized by profound metabolic reprogramming and an immunosuppressive tumor immune microenvironment (TIME). Lactate accumulation has recently been implicated in protein lactylation and tumor progression, but its role in reshaping the TIME in HCC remains incompletely understood. Objectives: To investigate how lactate-related metabolic reprogramming influences global protein lactylation and the TIME in HCC. Methods: We integrated high-throughput RNA sequencing, construction of a lactate metabolic process activity (LMPA) model, molecular subtyping, survival analysis and single-cell RNA sequencing to characterize lactate-associated alterations in HCC. Tissue microarrays and in vitro functional assays were used to validate key findings. Results: Elevated expression of lactate dehydrogenase A (LDHA), a core enzyme in lactate metabolism, was significantly associated with altered transcriptional profiles, unfavorable survival and changes in TIME composition in patients with HCC. In vitro, LDHA overexpression promoted HCC cell proliferation, migration and invasion. Patients with high LMPA exhibited significantly poorer prognosis and distinct immune infiltration patterns, including altered proportions of B cells, CD4+ T cells, neutrophils, macrophages, and dendritic cells. Single-cell RNA sequencing further revealed heterogeneous LMPA patterns across cell populations and increased global protein lactylation, particularly in immune cells. In addition, LMPA-based molecular subtypes were closely associated with lactylation-related features. LDHA expression, HDAC2 expression and metastasis were identified as significant prognostic factors. Conclusion: Lactate-related metabolic reprogramming may enhance global protein lactylation and remodel the TIME in HCC, thereby promoting tumor progression. These findings highlight the potential of targeting lactate metabolism and lactylation-associated pathways as novel therapeutic strategies for HCC.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.7.192.1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:28:24Z","timestamp":1779359304000},"source":"Crossref","is-referenced-by-count":1,"title":["Lactate Related Metabolic Reprogramming Increases Global Protein Lactylation And Remodels Tumor Immune Microenvironment Of Hepatocellular Carcinoma"],"prefix":"10.36721","author":[{"given":"Taiyu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Aran D, Hu Z and Butte AJ (2017). xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol., 18(1): 220.","DOI":"10.1186\/s13059-017-1349-1"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bergers G and Fendt SM (2021). The metabolism of cancer cells during metastasis. Nat. Rev. Cancer, 21(3): 162-180.","DOI":"10.1038\/s41568-020-00320-2"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Blanche P, Dartigues JF and Jacqmin-Gadda H (2013). Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med., 32(30): 5381-5397.","DOI":"10.1002\/sim.5958"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Brunson JC (2020). ggalluvial: Layered grammar for alluvial plots. J. Open Source Softw., 5(49): 2017.","DOI":"10.21105\/joss.02017"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Cai K, Fang Y, Zhang Y, Liu J, Ye Q, Ding L and Cai X (2024). Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis. PLoS One, 19(9): e0310391.","DOI":"10.1371\/journal.pone.0310391"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Cappuyns S, Pique-Gili M, Esteban-Fabro R, Philips G, Balaseviciute U, Pinyol R, Gris-Oliver A, Vandecaveye V, Abril-Fornaguera J, Montironi C, Bassaganyas L, Peix J, Zeitlhoefler M, Mesropian A, Huguet-Pradell J, Haber PK, Figueiredo I, Ioannou G, Gonzalez-Kozlova E, D'Alessio A, Mohr R, Meyer T, Lachenmayer A, Marquardt JU, Reeves HL, Edeline J, Finkelmeier F, Trojan J, Galle PR, Foerster F, Minguez B, Montal R, Gnjatic S, Pinato DJ, Heikenwalder M, Verslype C, Van Cutsem E, Lambrechts D, Villanueva A, Dekervel J and Llovet JM (2025). Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma. J. Hepatol., 82(6): 1036-1049.","DOI":"10.1016\/j.jhep.2024.12.016"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, Yao Y, Xu S, Ge S and Jia R (2025). Lactate and lactylation in cancer. Signal Transduct Target Ther., 10(1): 38.","DOI":"10.1038\/s41392-024-02082-x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Chen Y, Deng X, Li Y, Han Y, Peng Y, Wu W, Wang X, Ma J, Hu E, Zhou X, Shen E, Zeng S, Cai C, Qin Y and Shen H (2024). Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC. Hepatology, 80(3): 536-551.","DOI":"10.1097\/HEP.0000000000000869"},{"key":"ref8","unstructured":"Chen Z, Xie H, Hu M, Huang T, Hu Y, Sang N and Zhao Y (2020). Recent progress in treatment of hepatocellular carcinoma. Am. J. Cancer Res., 10(9): 2993-3036."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Cui Y, Liu J, Wang X, Wu Y, Chang Y, Hu X and Zhao W (2025). Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment. J. Adv Res., doi: 10.1016\/j.jare.2025.01.021. In press.","DOI":"10.1016\/j.jare.2025.01.021"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, Mu L, Luo X and Qin J (2025). Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis., 16(1): 193.","DOI":"10.1038\/s41419-025-07498-z"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ding CH, Yan FZ, Xu BN, Qian H, Hong XL, Liu SQ, Luo YY, Wu SH, Cai LY, Zhang X and Xie WF (2025). PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma. Cell Death Dis., 16(1): 158.","DOI":"10.1038\/s41419-025-07482-7"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H and Xiong J (2022). Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm. Sin. B., 12(2): 558-580.","DOI":"10.1016\/j.apsb.2021.09.019"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Giannone G, Ghisoni E, Genta S, Scotto G, Tuninetti V, Turinetto M and Valabrega G (2020). Immuno-metabolism and microenvironment in cancer: Key players for immunotherapy. Int. J. Mol. Sci., 21(12): 4414.","DOI":"10.3390\/ijms21124414"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Harding-Theobald E, Louissaint J, Maraj B, Cuaresma E, Townsend W, Mendiratta-Lala M, Singal AG, Su GL, Lok AS and Parikh ND (2021). Systematic review: Radiomics for the diagnosis and prognosis of hepatocellular carcinoma. Aliment. Pharmacol. Ther., 54(7): 890-901.","DOI":"10.1111\/apt.16563"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Huang A, Yang XR, Chung WY, Dennison AR and Zhou J (2020). Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther., 5(1): 146.","DOI":"10.1038\/s41392-020-00264-x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Huo J, Wu L and Zang Y (2021). Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma. J. Cell. Mol. Med., 25(2): 1151-1165.","DOI":"10.1111\/jcmm.16181"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV and Nie Q (2021). Inference and analysis of cell-cell communication using CellChat. Nat. Commun., 12(1): 1088.","DOI":"10.1038\/s41467-021-21246-9"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP and Tamayo P (2015). The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst., 1(6): 417-425.","DOI":"10.1016\/j.cels.2015.12.004"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B and Liu XS (2020). TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res., 48(W1): W509-W514.","DOI":"10.1093\/nar\/gkaa407"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Liu Y, Song J, Shi Q, Chen B, Qiu W, Liu Y, Huang S and He X (2024). Glucose-induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma. Clin. Transl. Med., 14(12): e70122.","DOI":"10.1002\/ctm2.70122"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Llibre A, Kucuk S, Gope A, Certo M and Mauro C (2025). Lactate: A key regulator of the immune response. Immunity, 58(3): 535-554.","DOI":"10.1016\/j.immuni.2025.02.008"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Long J, Wang A, Bai Y, Lin J, Yang X, Wang D, Yang X, Jiang Y and Zhao H (2019). Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine, 42: 363-374.","DOI":"10.1016\/j.ebiom.2019.03.022"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z and Tang W (2019). Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: Challenges and opportunities. Mol. Cancer, 18(1): 130.","DOI":"10.1186\/s12943-019-1047-6"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Nguyen NTB, Gevers S, Kok RNU, Burgering LM, Neikes H, Akkerman N, Betjes MA, Ludikhuize MC, Gulersonmez C, Stigter ECA, Vercoulen Y, Drost J, Clevers H, Vermeulen M, van Zon JS, Tans SJ, Burgering BMT and Rodriguez MJ (2025). Lactate controls cancer stemness and plasticity through epigenetic regulation. Cell Metab., 37(4): 903-919, e10.","DOI":"10.1016\/j.cmet.2025.01.002"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Oura K, Morishita A, Tani J and Masaki T (2021). Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: A review. Int. J. Mol. Sci., 22(11): 5801.","DOI":"10.3390\/ijms22115801"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Pedretti S, Palermo F, Braghin M, Imperato G, Tomaiuolo P, Celikag M, Boccazzi M, Vallelonga V, Da Dalt L, Norata GD, Marisi G, Rapposelli IG, Casadei-Gardini A, Ghisletti S, Crestani M, De Fabiani E and Mitro N (2025). D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma. Signal Transduct Target Ther., 10(1): 200.","DOI":"10.1038\/s41392-025-02282-z"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Rabinowitz JD and Enerback S (2020). Lactate: The ugly duckling of energy metabolism. Nat. Metab., 2(7): 566-571.","DOI":"10.1038\/s42255-020-0243-4"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Sartoris R, Gregory J, Dioguardi Burgio M, Ronot M and Vilgrain V (2021). HCC advances in diagnosis and prognosis: Digital and Imaging. Liver Int., 41(Suppl 1): 73-77.","DOI":"10.1111\/liv.14865"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Sheng H, Huang Y, Xiao Y, Zhu Z, Shen M, Zhou P, Guo Z, Wang J, Wang H, Dai W, Zhang W, Sun J and Cao C (2020). ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma. J. Immunother. Cancer, 8(1): e000340.","DOI":"10.1136\/jitc-2019-000340"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Tang B, Zhu J, Li J, Fan K, Gao Y, Cheng S, Kong C, Zheng L, Wu F, Weng Q, Lu C and Ji J (2020). The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun. Signal, 18(1): 174.","DOI":"10.1186\/s12964-020-00663-1"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS and Rinn JL (2014). The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol., 32(4): 381-386.","DOI":"10.1038\/nbt.2859"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sj\u00f6stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J and Pont\u00e9n F (2015). Tissue-based map of the human proteome. Science, 347(6220): 1260419.","DOI":"10.1126\/science.1260419"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Wang N, Tan HY, Lu Y, Chan YT, Wang D, Guo W, Xu Y, Zhang C, Chen F, Tang G and Feng Y (2021). PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma. Signal Transduct Target Ther., 6(1): 86.","DOI":"10.1038\/s41392-021-00485-8"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wang W and Wei C (2020). Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis., 7(3): 308-319.","DOI":"10.1016\/j.gendis.2020.01.014"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Wilkerson MD and Hayes DN (2010). Consensus ClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinform., 26(12): 1572-1573.","DOI":"10.1093\/bioinformatics\/btq170"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N and Chen W (2022). Cancer statistics in China and United States, 2022: Profiles, trends and determinants. Chin. Med. J. (Engl.), 135(5): 584-590.","DOI":"10.1097\/CM9.0000000000002108"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Xu F, Jin T, Zhu Y and Dai C (2018). Immune checkpoint therapy in liver cancer. J. Exp. Clin. Cancer Res., 37(1): 110.","DOI":"10.1186\/s13046-018-0777-4"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Yeh H, Chiang CC and Yen TH (2021). Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis and treatment challenges. World J. Gastroenterol., 27(26): 4104-4142.","DOI":"10.3748\/wjg.v27.i26.4104"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Yeo YH, Abdelmalek M, Khan S, Moylan CA, Rodriquez L, Villanueva A and Yang JD (2025). Current and emerging strategies for the prevention of hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol., 22(3): 173-190.","DOI":"10.1038\/s41575-024-01021-z"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Yu G, Wang LG, Han Y and He QY (2012). ClusterProfiler: An R package for comparing biological themes among gene clusters. OMICS, 16(5): 284-287.","DOI":"10.1089\/omi.2011.0118"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Zhang Y and Zhang X (2024). Virus-induced histone lactylation promotes virus infection in crustacean. Adv Sci. (Weinh.), 11(30): e2401017.","DOI":"10.1002\/advs.202401017"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q and Jin H (2025). Hepatocellular carcinoma: Signaling pathways and therapeutic advances. Signal Transduct Target Ther., 10(1): 35.","DOI":"10.1038\/s41392-024-02075-w"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Ziogas A, Novakovic B, Ventriglia L, Galang N, Tran KA, Li W, Matzaraki V, van Unen N, Schluter T, Ferreira AV, Moorlag S, Koeken V, Moyo M, Li X, Baltissen MPA, Martens JHA, Li Y, Divangahi M, Joosten LAB, Mhlanga MM and Netea MG (2025). Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell, 188(11): 2992-3012, e16.","DOI":"10.1016\/j.cell.2025.03.048"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:40:06Z","timestamp":1788180006000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":44,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.7.192.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}